Court Orders Apple to Pay Masimo $184M
A U.S. court ordered Apple to pay Masimo $184.2M in prejudgment interest, adding to a $634M patent infringement award, totaling $818M. Masimo accused Apple of poaching talent and copying its blood-oxygen tech for the Apple Watch. The judge rejected Apple's argument against the interest. Masimo, now under Danaher, continues to expand its patient monitoring offerings.
How this was made

The 30-second read
Why it matters
The court's interest award significantly raises the total financial exposure for Apple while delivering a larger recovery for Masimo, influencing both companies' balance sheets and investor sentiment.
Market read
The ruling adds a material liability for Apple and a sizable cash inflow for Masimo, likely moving both stocks in the short term.
What to watch
Potential insurance recoveries or settlement negotiations could reduce the net payment.
Background
Apple and Masimo have been embroiled in a multi‑year patent dispute over blood‑oxygen monitoring technology used in the Apple Watch.
Ticker impact
Apple was ordered to pay $184.2M in prejudgment interest, adding to a $634M verdict, increasing total liability to over $818M.
likely pressure as investors factor the $184M interest payment and total $818M exposure.
The court order is a fresh, material liability that could affect earnings and cash flow.
Market effects
Highlights patent risk in med‑tech and consumer‑electronics, may prompt tighter IP diligence.
U.S. markets may see modest volatility in healthcare and tech stocks.
Sets precedent for large IP judgments, could affect global tech‑med‑tech partnerships.
Counterpoint
Apple may appeal the interest calculation, limiting the actual cash outflow.
Key entities
- CompanyApple Inc.
U.S. technology giant ordered to pay additional interest.
- CompanyMasimo Corp.
Medical‑technology firm receiving the increased award.
- Legal BodyU.S. District Court for the Central District of California
Issued the ruling on interest payments.


